Your browser doesn't support javascript.
loading
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Ribi, Karin; Luo, Weixiu; Colleoni, Marco; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Di Lauro, Vincenzo; Gomez, Henry L; Ruhstaller, Thomas; Abdi, Ehtesham; Biganzoli, Laura; Müller, Bettina; Barbeaux, Annelore; Graas, Marie-Pascale; Rabaglio, Manuela; Francis, Prudence A; Foukakis, Theodoros; Pagani, Olivia; Graiff, Claudio; Vorobiof, Daniel; Maibach, Rudolf; Di Leo, Angelo; Gelber, Richard D; Goldhirsch, Aron; Coates, Alan S; Regan, Meredith M; Bernhard, Jürg.
Afiliação
  • Ribi K; Quality of Life Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.
  • Luo W; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy/Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
  • Chirgwin J; Box Hill and Maroondah Hospitals, Monash University, Victoria, Australia.
  • Aebi S; Luzerner Kantonsspital, Lucerne, Switzerland.
  • Jerusalem G; CHU Liège, Liège University, Liège, Belgium.
  • Neven P; Multidisciplinary Breast Center, University Hospitals, KU Leuven, Leuven, Belgium.
  • Di Lauro V; Division of Medical Oncology B, CRO-Aviano, Aviano, Italy.
  • Gomez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
  • Ruhstaller T; Breast Center St. Gallen, Swiss Group for Clinical Cancer Research and International Breast Cancer Study Group, Bern, Switzerland.
  • Abdi E; The Tweed Hospital, Tweed Heads, NSW & Griffith University Gold Coast, Southport, Australia.
  • Biganzoli L; Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy.
  • Müller B; Chilean Cooperative Group for Oncologic Research (GOCCHI), Providencia, Santiago, Chile.
  • Barbeaux A; CHR Verviers, Verviers, Belgium.
  • Graas MP; CHC Clinique St. Joseph, Liège, Belgium.
  • Rabaglio M; Bern University Hospital, Inselspital, Bern, Switzerland.
  • Francis PA; Peter MacCallum Cancer Center, University of Melbourne, Melbourne and Breast Cancer Trials Australia & New Zealand, University of Newcastle, Newcastle, Australia.
  • Foukakis T; Department of Oncology, Karolinska Institute and University Hospital, Stockholm, Sweden.
  • Pagani O; Institute of Oncology of Southern Switzerland, Bellinzona, Geneva University Hospitals, Geneva, Swiss Group for Clinical Cancer Research (SAKK) and International Breast Cancer Study Group, Bern, Switzerland.
  • Graiff C; Division of Medical Oncology, Ospedale Centrale di Bolzano, Bolzano, Italy.
  • Vorobiof D; Sandton Oncology Centre, Johannesburg, South Africa.
  • Maibach R; International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.
  • Di Leo A; Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy.
  • Gelber RD; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA.
  • Goldhirsch A; International Breast Cancer Study Group and IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Coates AS; International Breast Cancer Study Group and University of Sydney, Sydney, Australia.
  • Regan MM; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Bernhard J; Quality of Life Office, International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland. juerg.bernhard@ibcsg.org.
Br J Cancer ; 122(7): 1119, 2020 Mar.
Article em En | MEDLINE | ID: mdl-31949268
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça